Capitalizing on precision medicine : how pharmaceutical firms can shape the future of healthcare

<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<rdf:Description>
<dc:creator>Danner, Stephan</dc:creator>
<dc:creator>Solbach, Dr. Thomas</dc:creator>
<dc:creator>Ludwig, Mark</dc:creator>
<dc:creator>PricewaterhouseCoopers</dc:creator>
<dc:date>2017</dc:date>
<dc:description xml:lang="es">Sumario: Precision medicine holds tremendous potential to remake the healthcare industry. By applying a deeper understanding of diseases with richer patient data and advanced analytics, precision medicine can help physicians tailor medicines to the needs of individual patients, rather than by broader populations, leading to better outcomes at potentially lower costs.</dc:description>
<dc:identifier>https://documentacion.fundacionmapfre.org/documentacion/publico/es/bib/163779.do</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>PricewaterhouseCoopers</dc:publisher>
<dc:rights xml:lang="es">InC - http://rightsstatements.org/vocab/InC/1.0/</dc:rights>
<dc:subject xml:lang="es">Industria farmacéutica</dc:subject>
<dc:subject xml:lang="es">Salud Digital</dc:subject>
<dc:subject xml:lang="es">Nuevas tecnologías</dc:subject>
<dc:subject xml:lang="es">Atención sociosanitaria</dc:subject>
<dc:subject xml:lang="es">Medicina de precisión</dc:subject>
<dc:type xml:lang="es">Livros</dc:type>
<dc:title xml:lang="es">Capitalizing on precision medicine  : how pharmaceutical firms can shape the future of healthcare</dc:title>
</rdf:Description>
</rdf:RDF>